CRISPR Therapeutics AG (CRSP) has a market capitalization of $5.46B and trades at $56.86. The 52-week range is 30.04-78.48.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -8.8, Earnings Per Share (EPS) of $-6.47, annual revenue of $3.51M.
The stock has a beta of 1.79, operates in the Healthcare sector.
